Generic Drugs Need Government Support, House Health Subcommittee Admits

Generic Drugs Need Government Support, House Health Subcommittee Admits

U.S. based generic drug makers need government support to expand – and maybe even to survive – the onslaught of imports nearly every member of the House Energy and Commerce Committee Subcommittee on Health said in a hearing on Wednesday.

Tariffs, Industrial Policies Like the CHIPS Act, Help Protect U.S. From ‘China Shock 2.0’

Tariffs, Industrial Policies Like the CHIPS Act, Help Protect U.S. From ‘China Shock 2.0’

The second round of the early 2000s ‘China Shock’ will impact the rest of the world more than it will the United States. Tariffs and industrial policies – like the CHIPS Act and the Inflation Reduction Act – have somewhat protected the U.S. from China’s relentless exports.

Overregulation and Foreign Competition Dominate House Hearing on U.S. Seafood; Tariffs Mentioned But Not Embraced as Solution

Overregulation and Foreign Competition Dominate House Hearing on U.S. Seafood; Tariffs Mentioned But Not Embraced as Solution

At a June 4 hearing before the House Natural Resources Committee’s Water, Wildlife and Fisheries Subcommittee, lawmakers and industry representatives expressed growing frustration with what they described as an overregulated domestic seafood industry that is steadily losing ground to foreign competition.

Sen. Kennedy Just Gave Howard Lutnick Best Example Why Reciprocal Tariffs Don’t Work

Sen. Kennedy Just Gave Howard Lutnick Best Example Why Reciprocal Tariffs Don’t Work

By the time the Committee hearing with Lutnick was over, it seemed pretty clear that the Trump administration has shifting ideas about reciprocity today, and are less sure about the nature of them than they were before “Liberation Day” on April 2.

Tariffs and Capital Tools to Revive American Trade Policy

Tariffs and Capital Tools to Revive American Trade Policy

Decades of misguided trade policies have transformed the United States into the world’s consumer of last resort, absorbing the world’s excess savings at the expense of its manufacturing sector. U.S.-imposed tariffs are the first step towards rebalancing the system, but they aren’t sufficient.

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

The American pharmaceutical supply chain has become dangerously dependent on imports and foreign-controlled supply chains. Over the past 20 years, the country has experienced a skyrocketing rate on pharmaceutical imports and increasing foreign reliance.